<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">1275002</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4431</journal-id>
<journal-id journal-id-type="nlm-ta">J Allergy Clin Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Allergy Clin. Immunol.</journal-id>
<journal-title-group>
<journal-title>The Journal of allergy and clinical immunology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0091-6749</issn>
<issn pub-type="epub">1097-6825</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27720020</article-id>
<article-id pub-id-type="pmc">5074686</article-id>
<article-id pub-id-type="doi">10.1016/j.jaci.2016.08.003</article-id>
<article-id pub-id-type="manuscript">NIHMS815566</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Exome and genome sequencing for inborn errors of immunity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Meyts</surname>
<given-names>Isabelle</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="author-notes" rid="FN1">*</xref>
<aff id="A1">Department of Immunology and Microbiology, Childhood Immunology, Department of Pediatrics, University Hospitals Leuven and KU Leuven, Leuven, Belgium</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bosch</surname>
<given-names>Barbara</given-names>
</name>
<degrees>MD</degrees>
<aff id="A2">Department of Pediatrics, University Hospitals Leuven and KU Leuven Belgium</aff>
<aff id="A3">St. Giles Laboratory of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bolze</surname>
<given-names>Alexandre</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A4">St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065</aff>
<aff id="A5">Helix, 1 Circle Star Way, San Carlos, CA 94070</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boisson</surname>
<given-names>Bertrand</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A6">St. Giles Laboratory of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA</aff>
<aff id="A7">The Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France</aff>
<aff id="A8">Paris Descartes University, Imagine Institute, Paris, France</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Itan</surname>
<given-names>Yuval</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A9">St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Belkadi</surname>
<given-names>Aziz</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A10">Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, 75015 Paris, FranceFrance</aff>
<aff id="A11">Imagine Institute, Paris Descartes University, 75015 Paris, France</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pedergnana</surname>
<given-names>Vincent</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A12">Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, 75015 Paris, France</aff>
<aff id="A13">Imagine Institute, Paris Descartes University, 75015 Paris, France</aff>
<aff id="A14">Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moens</surname>
<given-names>Leen</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A15">Laboratory Medicine, Experimental Laboratory Immunology, Department of Laboratory Medicine, University Hospitals Leuven and KU Leuven, Leuven, Belgium</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Picard</surname>
<given-names>Capucine</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A16">Paris Descartes University – Sorbonne Paris Cité, Paris, FranceStudy Center for Immunodeficiency, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Institut IMAGINE, Paris, France</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cobat</surname>
<given-names>Aurélie</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A17">Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, 75015 Paris, France</aff>
<aff id="A18">Imagine Institute, Paris Descartes University, Paris, France</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bossuyt</surname>
<given-names>Xavier</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A19">Laboratory Medicine, Experimental Laboratory Immunology, Department of Laboratory Medicine, University Hospitals Leuven and KU Leuven, Leuven, Belgium</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abel</surname>
<given-names>Laurent</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A20">St. Giles Laboratory of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA</aff>
<aff id="A21">The Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris Descartes University, Imagine Institute, Paris, France</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Casanova</surname>
<given-names>Jean-Laurent</given-names>
</name>
<degrees>MD, PhD</degrees>
<aff id="A22">St. Giles Laboratory of Infectious Diseases, Rockefeller Branch, The Rockefeller University; the Howard Hughes Medical Institute, New York, New York, USA</aff>
<aff id="A23">The Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children; the Imagine Institute, Paris Descartes University; and the Pediatric Hematology and Immunology Unit, Assistance Publique-Hôpitaux de Paris, Necker Hospital for Sick Children, Paris, France</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="FN1"><label>*</label>correspondence <email>Isabelle.Meyts@uzleuven.be</email>; Isabelle Meyts, Department of Pediatrics, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium, Tel 003216343841 Fax 003216343842</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2017</year>
</pub-date>
<volume>138</volume>
<issue>4</issue>
<fpage>957</fpage>
<lpage>969</lpage>
<!--elocation-id from pubmed: 10.1016/j.jaci.2016.08.003-->
<abstract>
<p id="P1">The advent of next generation sequencing (NGS) in 2010 has transformed medicine and particularly the growing field of monogenic inborn errors of immunity, including primary immunodeficiencies (PID). NGS has facilitated the discovery of novel disease-causing genes and the genetic diagnosis of patients with PID. Whole-exome sequencing (WES) is presently the most cost-effective approach for PID research and diagnostics, though whole genome sequencing (WGS) offers several advantages. The scientific or diagnostic challenge consists in selecting one or two candidate variants among thousands of NGS calls. Variant- and gene-level computational methods as well as immunological hypotheses can help to narrow down this genome-wide search. The key to success is a well-informed genetic hypothesis on three key aspects: mode of inheritance, clinical penetrance, and genetic heterogeneity of the condition. This determines the search strategy and the frequency cut-offs for candidate alleles. Subsequent functional validation of the disease-causing effect of the candidate variant is critical. Even the most up-to-date dry lab cannot clinch this validation without a seasoned wet lab. The multifariousness of variations entails an experimental rigor even greater than traditional Sanger sequencing-based approaches, in order not to assign PID to false positives. Finding the needle in the haystack takes patience, prudence, and discernment.</p>
</abstract>
<kwd-group>
<kwd>Next generation sequencing</kwd>
<kwd>Whole exome sequencing</kwd>
<kwd>Whole genome sequencing</kwd>
<kwd>Targeted sequencing</kwd>
<kwd>Primary immunodeficiency</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>